This page contains press release content distributed by XPR Media. Members of the editorial and news staff of the USA TODAY Network were not involved in the creation of this content.

Metavalis Launches Massive Community Coat Drive in Branson to Support Local Residents

Metavalis Inc.

Emerging biotech firm debuts “Science & Shield” initiative, bridging the gap between advanced medical research and immediate humanitarian relief for the Ozarks.

BRANSON, Mo., Jan. 27, 2026 / PRZen / Metavalis, a biotechnology innovator developing a proprietary Stealth Lipid Nanoparticle (LNP) platform, is proud to announce the launch of its “Science & Shield” humanitarian initiative. To mark this milestone, the company has partnered with community organizers to host a massive winter aid event in Branson.

While Metavalis is pioneering a new generation of stealth delivery systems to tackle rare and challenging diseases, the company’s leadership maintains that advanced science must be paired with immediate community care.

“Our stealth LNP technology is designed to go where other treatments can’t, solving the hardest problems in medicine,” said Jordan Bekemeier, Founder and CEO of Metavalis. “But while we engineer solutions for the future, we also have to solve the problems right in front of us. That is why we are deploying resources today not just in the lab, but in the parking lot, handing out supplies to neighbors who are struggling.”

Event Details:

Date: Saturday, February 7, 2026
Time: 12:00 PM – 3:00 PM CST
Location: 993 Branson Hills Parkway, Branson, MO (Parking lot)

A Dual Layer of Support The event is a coordinated effort to provide comprehensive winter protection:

The Davis Family will be distributing a massive supply of winter coats, hats, and heavy weather gear to protect against the cold.
Metavalis will be distributing “Shield Kits” care packages containing non perishable food, first aid supplies (band aids, sanitizers), and hygiene essentials.

About Metavalis Metavalis is a biotechnology company focused on the treatment of rare and challenging diseases through its novel Stealth LNP platform. By engineering delivery vehicles that evade immune detection, Metavalis aims to unlock new possibilities in genetic medicine. The “Science & Shield” program represents the company’s commitment to protecting human life at every level from the cellular to the community.

For more information, visit the Metavalis website.

Contact
Jordan Bekemeier (Founder & CEO)
Metavalis
(417) 243-9965
jordan@metavalis.com

Press Release Distributed by PRLog

Source: Metavalis Inc.

Follow the full story here: https://przen.com/pr/33604183

Information contained on this page is provided by an independent third-party content provider. XPRMedia and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact pressreleases@xpr.media